This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms | MicrobiomeTrials
← Back to trials NCT07094750
Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-07-01Est. Completion: 2029-06-08
Enrollment target: 50 participantsLocations Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States Other microbiome trials you might be interested in Acute Myeloid Leukemia Blasts 20 Percent or More of Bone Marrow Nucleated Cells High Risk Myelodysplastic Syndrome Recurrent Acute Biphenotypic Leukemia Recurrent Acute Myeloid Leukemia Recurrent High Risk Myelodysplastic Syndrome Refractory Acute Myeloid Leukemia Refractory High Risk Myelodysplastic Syndrome
This phase I/II trial studies the side effects and how well cladribine, idarubicin, cytarabine, and quizartinib work in …
Houston, United States Est. completion Dec 31, 2027
Phase 2
Recruiting
Acute Leukemia of Ambiguous Lineage B Acute Lymphoblastic Leukemia
This phase II trial tests the addition of venetoclax and/or blinatumomab to usual chemotherapy for treating infants with…
Birmingham, United States Est. completion Dec 31, 2028